R
Raffaele Liuzzi
Researcher at National Research Council
Publications - 116
Citations - 2502
Raffaele Liuzzi is an academic researcher from National Research Council. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 28, co-authored 112 publications receiving 2153 citations. Previous affiliations of Raffaele Liuzzi include University of Naples Federico II.
Papers
More filters
Journal ArticleDOI
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Rosa Fonti,Barbara Salvatore,Mario Quarantelli,Cesare Sirignano,Sabrina Segreto,Fara Petruzziello,Lucio Catalano,Raffaele Liuzzi,Bruno Rotoli,Silvana Del Vecchio,Leonardo Pace,Marco Salvatore +11 more
TL;DR: MRI should be reserved to the evaluation of bone marrow involvement of these districts, whereas 18F-FDG PET/CT can significantly contribute to an accurate whole-body evaluation of MM patients, and whole- body 99mTc-MIBI, despite its limited capacity in detecting focal lesions, may be an alternative option when a PET facility is not available.
Journal ArticleDOI
Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy
Marcello Mancini,Anna Prinster,Giovanni Annuzzi,Raffaele Liuzzi,Rosalba Giacco,Carmela Medagli,Matteo Cremone,Gennaro Clemente,Simone Maurea,Gabriele Riccardi,Angela A. Rivellese,Marco Salvatore +11 more
TL;DR: US H/R exhibits high sensitivity and specificity for detecting liver fatty changes and could therefore be a valuable analytic tool in clinical investigation, and indicates that quantitative evaluation of hepatic fat content can be performed using US H/r.
Journal ArticleDOI
Thyroid v30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for hodgkin's lymphoma
Laura Cella,Manuel Conson,Michele Caterino,Nicola De Rosa,Raffaele Liuzzi,Marco Picardi,Francesco Grimaldi,Raffaele Solla,A. Farella,Marco Salvatore,Roberto Pacelli +10 more
TL;DR: The thyroid V30 predicts the risk of developing HT after sequential chemo-radiotherapy and defines a useful constraint to consider for more accurate HL treatment planning.
Journal ArticleDOI
Effects of enzyme-replacement therapy in patients with Anderson–Fabry disease: a prospective long-term cardiac magnetic resonance imaging study
Massimo Imbriaco,Antonio Pisani,Letizia Spinelli,Alberto Cuocolo,Giancarlo Messalli,Ermanno Capuano,Mario Marmo,Raffaele Liuzzi,Bianca Visciano,Bruno Cianciaruso,Marco Salvatore +10 more
TL;DR: Long-term therapy with agalsidase beta at 1 mg/kg every 2 weeks was effective in significantly reducing LV hypertrophy, improving overall cardiac performance and ameliorating clinical symptoms in patients with Anderson–Fabry disease.
Journal ArticleDOI
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
Giovanni Storto,Michele Klain,Gaetano Paone,Raffaele Liuzzi,Leonardo Molino,Alfredo Marinelli,Andrea Soricelli,Leonardo Pace,Marco Salvatore +8 more
TL;DR: It is indicated that combined therapy of 89Sr-chloride and zoledronic acid in patients with painful bone metastases is more effective in treating pain and improving clinical conditions than 89SR- chloride or zoledronics acid used separately.